These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 21488076)

  • 1. Risk factors for cholangiocarcinoma.
    Tyson GL; El-Serag HB
    Hepatology; 2011 Jul; 54(1):173-84. PubMed ID: 21488076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for cholangiocarcinoma.
    Ben-Menachem T
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of cholangiocarcinoma.
    Bergquist A; von Seth E
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
    Ehlken H; Schramm C
    Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of cholangiocarcinoma.
    Shaib Y; El-Serag HB
    Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
    Plentz RR; Malek NP
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation.
    Chung YE; Kim MJ; Park YN; Choi JY; Pyo JY; Kim YC; Cho HJ; Kim KA; Choi SY
    Radiographics; 2009; 29(3):683-700. PubMed ID: 19448110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New epidemiologic trends in cholangiocarcinoma.
    Pascale A; Rosmorduc O; Duclos-Vallée JC
    Clin Res Hepatol Gastroenterol; 2023 Nov; 47(9):102223. PubMed ID: 37797807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathology of cholangiocarcinoma].
    Guedj N; Bedossa P; Paradis V
    Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hilar cholangiocarcinoma: pathology and tumor biology.
    Kuang D; Wang GP
    Front Med China; 2010 Dec; 4(4):371-7. PubMed ID: 21110142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of early cancer in cystic intrahepatic duct associated with congenital choledochal cyst.
    Kawamoto S; Hiraoka T; Maruta S; Watanabe E; Kanemitsu K; Tsuji T
    Hepatogastroenterology; 1998; 45(20):428-32. PubMed ID: 9638419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the incidence of biliary carcinoma in choledochal cysts, when do they develop, and how should it affect management?
    Sastry AV; Abbadessa B; Wayne MG; Steele JG; Cooperman AM
    World J Surg; 2015 Feb; 39(2):487-92. PubMed ID: 25322698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of intrahepatic cholangiocarcinoma associated with Type IV choledochal cyst].
    Kim SH; Kim HW; Kang DH; Kim MD; Lee JH; Lee JH; Kim BG; Park JH
    Korean J Gastroenterol; 2012 Aug; 60(2):123-7. PubMed ID: 22926125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?
    de Groen PC
    Hepatology; 2000 Jan; 31(1):247-8. PubMed ID: 10613754
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatobiliary malignancy.
    Jones BA; Gores GJ
    Clin Liver Dis; 1998 May; 2(2):437-49, xi-xii. PubMed ID: 15560042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma: expanding the spectrum of risk factors.
    Elfaki DH; Gossard AA; Lindor KD
    J Gastrointest Cancer; 2008; 39(1-4):114-7. PubMed ID: 19142590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risk, screening and surveillance in primary sclerosing cholangitis.
    Chascsa DM; Lindor KD
    Minerva Gastroenterol Dietol; 2019 Sep; 65(3):214-228. PubMed ID: 31220911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.